Increasing the diversity of clinical trial participants is all the rage these days. The numbers tell the story: According to Food and Drug Administration data,
Source: MedCity News Conducting a successful clinical trial depends on well-designed patient recruitment procedures and retaining the research participants until the completion of the study.
JoTo PR Disruptors’ signs Jeeva Trials, a human-centric Software as a Service (SaaS) company that is working to revolutionize the clinical trials space at scale.
Clinical trials are expensive, take significant time, and can run into any number of challenges and delays. The average drug study will see a 30%
Source: PubsOnline Over the past two years, the testing of new medical devices, drugs and vaccines has increasingly been performed outside large medical centers. Faster
Source: ACRP There’s more to the quest of fostering diversity, equity, and inclusion in the delivery of clinical research opportunities than just reaching race/ethnicity-, gender-,
Maximizing Clinical Trial Access, Diversity, and Efficiency are Keys to Optimizing Orphan Drug Development February 22, 2022 February is Rare Disease Month—an important time when
Source: Insightcare By Harsha Rajasimha, PhD, Founder and CEO, Jeeva Clinical Trials Inc. www.jeevatrials.com To say that COVID-19 has been a challenge to healthcare systems
The COVID-19 pandemic brought a new sense of appreciation for clinical trials as masses watched clinical trials closely while pharmaceutical companies raced against the clock
Source: MarketScale Clinical trials can save lives and provide new ways to treat disease. The industry estimates that 85% of all clinical trials face delays
Jeeva Clinical Trials Inc.
